10/12/2026
Don't miss this week's AAPS eChalk Talk!
Beyond Probe Drugs: Biomarker-Based Assessment of CYP3A Drug-Drug Interaction Risk
π
October 14, 2026
ποΈ 1:15 PM ET
Registration >>> https://science360.aaps.org/science360/2026/webinars/4236914/
Evaluating CYP3A inhibition and induction is an important consideration in clinical drug development. This session presented by Sarah Oehm, PhD, and moderated by Katherine Yahvah, PhD, will share an LC-MS/MS assay developed by Alturas Analytics to simultaneously measure three endogenous CYP3A biomarkers in human plasma, providing a way to evaluate CYP3A activity without administering a traditional probe substrate.
Register today >>> https://science360.aaps.org/science360/2026/webinars/4236914/